Early expression of E-selectin, tumor necrosis factor α, and mast cell infiltration in the salivary glands of patients with systemic sclerosis

Arthritis and Rheumatism

Volumn 39, Issue 7, 1996, Pages 1161-1165

  Hebbar, Mohamed ^a   Gillot, Jean Michel ^a   Hachulla, Eric ^a   Lassalle, Philippe ^a   Hatron, Pierre Yves ^a   Devulder, Bernard ^a   Janin, Anne ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; DISEASE PREDISPOSITION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; MALE; MAST CELL; PRIORITY JOURNAL; RAYNAUD PHENOMENON; RISK ASSESSMENT; SIALOADENITIS; SYSTEMIC SCLEROSIS;

EID: 0029984152     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780390713     Document Type: Article

References (25)

1. Allen EV, Brown GE: Raynaud's disease: a critical review of minimal requisites for diagnosis. Am J Med Sci 183:187-200, 1932
2. Harper FE, Maricq HR, Turner RE, Lidman RW, Le Roy EC: A prospective study of Raynaud's phenomenon and early connective tissue disease: a five-year report. Am J Med 72:883-888, 1982
3. Gerbracht DD, Steen VD, Ziegler GL, Medsgcr TA Jr, Rodnan GP: Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease. Arthritis Rheum 28:87-92, 1985
4. Fitzgerald O, Hess EV, O'Connor GT, Spencer-Green G: Prospective study of the evolution of Raynaud's phenomenon. Am J Med 84:718-726, 1988
5. Fleischmajer R: The pathophysiology of scleroderma. Int J Dermatol 16:310-318, 1977
6. Fiessinger JN, Blanchet-Bardon C, Droullat JP: Rapports entre la sclerodermie et le syndrome de Sjögren: intérêt de la biopsie systématique des glandes salivaires labiales. Presse Med 4:3177-3180, 1975
7. Janin A, Gosselin D, Gosset D, Hatron PY, Sauvezie B: Histological criteria of Sjögren's syndrome in scleroderma. Clin Exp Rheumatol 7:167-169, 1989
8. Campbell PM, LeRoy EC: Pathogenesis of systemic sclerosis: a vascular hypothesis. Semin Arthritis Rheum 4:351-367, 1975
9. Claman HN, Giorno RC, Seibold JR: Endothelial and fibroblastic activation in scleroderma: the myth of the "uninvolved" skin. Arthritis Rheum 34:1495-1501, 1991
10. Bevilacqua MP, Pober JS, Mendrick DL, Cotran RS, Gimbrone MA Jr: Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA 84:9238-9242, 1987
11. Leeuwenberg JFM, Jeunhomme TMAA, Buurman WA: Role of ELAM-1 in adhesion of monocytes to activated human endothelial cells. Scand J Immunol 35:335-341, 1992
12. Hebbar M, Lassalle P, Janin A, Vanhée D, Bisiau S, Hatron P-Y, Tonnel A-B, Gosselin B: E-selectin expression in salivary endothelial cells and sera from patients with systemic sclerosis: role of resident mast cell-derived tumor necrosis factor α. Arthritis Rheum 38:406-412, 1995
13. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581-590, 1980
14. Maricq HR, Spencer-Green G, Le Roy EC: Skin capillary abnormalities as indicators of organ involvement in scleroderma (systemic sclerosis), Raynaud's syndrome, and dermatomyositis. Am J Med 61:862-870, 1976
15. Chisholm DM, Mason DK: Labial salivary gland biopsy in Sjögren's disease. J Clin Pathol 21:656-660, 1968
16. Wigley FM: Raynaud's phenomenon. Curr Opin Rheumatol 5:773-784, 1993
17. Priollet P, Vayssairat M, Housset E: How to classify Raynaud's phenomenon? Long-term follow-up study of 73 cases. Am J Med 83:494-498, 1987
18. Janes J, McDonald JR: Mast cells: their distribution in various human tissues. Arch Pathol 45:622-634, 1948
19. Hawkins RA, Claman HN, Clark RAF, Steigerwald JC: Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis. Ann Intern Med 102:182-186, 1985
20. Nishioka K, Kobayashi Y, Katayama I, Takajiri C: Mast cell numbers in diffuse scleroderma. Arch Dermatol 123:205-208, 1987
21. Seibold JR, Giorno RC, Claman HR: Dermal mast cell degranulation in systemic sclerosis. Arthritis Rheum 33:1702-1709, 1990
22. Claman HN: On scleroderma: mast cells, endothelial cells, and fibroblasts. JAMA 262:1206-1209, 1989
23. Russel JD, Russel SB, Trupin KM: The effects of histamine on the growth of cultured fibroblasts isolated from normal and keloid tissue. J Cell Physiol 93:389-394, 1977
24. Gordon JR, Galli SJ: Promotion of mouse fibroblast collagen gene expression by mast cells stimulated via the Fcε RI: role for mast cell-derived transforming growth factor β and tumor necrosis factor α. J Exp Med 180:2027-2037, 1994
25. Kahari VM, Chen YQ, Su MW, Ramirez F, Uitto J: Tumor necrosis factor α and interferon-γ suppress the activation of human type I collagen gene expression by transforming growth factor β1: evidence for two distinct mechanisms of inhibition at the transcriptional and posttranscriptional levels. J Clin Invest 86: 1489-1495, 1990